The crosstalk between PLK4 and c-GAS-STING pathways was reported in acute myeloid leukemia where PLK4 inhibition using a small molecule inhibitor (CFI-400945) activated antitumor immune response via the c-GAS-STING pathway in TP53-mutated leukemia cells. This evidence concerns the gene STING1 and leukemia.